Navigation Links
New blood clot guidelines for pregnant women
Date:6/24/2008

New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies. Published as a supplement in the June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), Antithrombotic and Thrombolytic Therapy: ACCP Evidence-Based Clinical Practice Guidelines, Eighth Edition was developed by an international panel of 90 experts and includes more than 700 of the most comprehensive recommendations related to the prevention, treatment, and long-term management of thrombotic disorders. The guidelines include chapters on the challenges in preventing and treating thrombosis in pregnant women and children, and on managing peri- and postoperative patients, while also reinforcing previous guidelines related to the routine use of preventive therapies, including aspirin.

"For years, clinicians have faced challenges in preventing and managing thrombosis in women who are pregnant or patients who require surgery," said guidelines panel chair Jack Hirsh, MD, FCCP, Henderson Research Center, Hamilton, ON, Canada. "The new guidelines address many troublesome issues in antithrombotic therapy and provide clinicians with a variety of options for care in special patient groups." Antithrombotic and thrombolytic therapies are used to prevent and treat thrombosis or blood clotting that arises in arteries, veins, and the heart.

PREGNANT WOMEN

The new ACCP guidelines address challenging issues facing women who are pregnant or wish to become pregnant while undergoing long-term antithrombotic therapy. Pregnant women taking vitamin K antagonists (VKA), such as the anticoagulant warfarin, have an increased risk for birth defects and miscarriage and are, therefore, advised to stop taking VKAs before 6 weeks of fetal gestation. However, some pregnant women with certain types of mechanical heart valve
'/>"/>

Contact: Jennifer Stawarz
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Local Blood Supply at Low Levels
2. Study in Circulation provides detail on how low blood flow promotes vascular disease
3. Symptom Screening Plus a Simple Blood Test Equals a 20 Percent Jump in Early Detection of Ovarian Cancer
4. Symptoms Plus Blood Test Boost Ovarian Cancer Detection
5. Symptom screening plus a simple blood test improves early detection of ovarian cancer
6. Blood Substitute Found Safe in Large Phase III Trial
7. Low Blood Sodium Predicts Mortality in PAH Patients
8. MetLife Foundation Partners with New York Blood Center to Introduce Donor Coach to New York Boroughs
9. Cord Blood America Says Pennsylvania Joins New York and California in Informing Parents of the Advantages of Umbilical Cord Blood Storage
10. New cancer treatment targets both tumor cells and blood vessels
11. Computers as safe as medical experts in prescribing blood thinning drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... While deep learning was the topic of ... (GTC) , the CEO of one start-up spoke passionately about ... lifespan well beyond the generally-agreed ceiling of 120 years. , ... one of 12 companies recognized as the hottest GPU-powered startups ... GTC Emerging Companies Summit have business models focused ...
(Date:3/27/2015)... KING OF PRUSSIA, PA and LONDON, UK (PRWEB) March ... and current President of DrugDev SiteStart Melissa (Liss) Easy ... Under 40. , The 40 Under 40 list ... of age for their professional accomplishments and community involvement. ... and profiled in a special supplement of the Philadelphia ...
(Date:3/27/2015)... The report “CountryFocus: Healthcare, Regulatory and ... information on and analysis of the healthcare, regulatory and ... US in 2013 amounted to 316.1 million, having grown ... from 2008. The country’s increasingly elderly population and corresponding ... to boost the growth of the pharmaceutical market, which ...
(Date:3/27/2015)... 2015 SMI (Silicon Microstructures, Inc.), a ... launched the SM1120 MEMS based ultra-miniature pressure sensor designed ... profile at only 220um x 75um provides ample space ... locations. With industry leading in vivo drift performance ... a broad operating pressure range from 0 to 1,100 ...
(Date:3/27/2015)... When struck with the aftermath of a ... to begin. The latest eBook released by Dax ... accident victims a clear and concise process for obtaining ... personal injury claim is seen through to successful completion. ... that should be taken immediately following the trucking incident. ...
Breaking Medicine News(10 mins):Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2
... data about the safety of drug-,eluting stents (DES) ... cardiovascular disease, according to The Society for,Cardiovascular Angiography ... crucial importance of training physicians in the proper,selection ... a,strict regimen of medications that prevent blood clots ...
... as a troublemaker for triggering the itch and inflammation in ... flare-ups, researchers from Stanford University School of Medicine have found. ... online version of Nature Immunology, reveal that, in mice, mast ... or from poison oak. , "These reactions are much worse ...
... that looked at inequalities in patients access to cancer drugs ... the September issue of the cancer journal, Annals of Oncology ... badly flawed that no safe conclusions can be drawn from ... by a major drug company in funding the research. , ...
... an important drug used in the treatment of malignant melanoma ... activates immune-system cells to fight the disease. , The ... microscopic tumor cells that may remain in the body following ... for this purpose. , Researchers say that these findings ...
... of butter flavoring in microwave brands , SATURDAY, Sept. 1 ... flavoring of microwave popcorn has been identified as a likely ... who work in the microwave popcorn manufacturing industry, Dutch researchers ... the American Journal of Respiratory and Critical Care Medicine ...
... The first investigation of developmental sleep duration patterns throughout ... get little sleep are more likely to have behavioral ... study published in the September 1 issue of the ... MD, of the Sleep Disorders Center at Sacre-Coeur Hospital ...
Cached Medicine News:Health News:Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up 2Health News:Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up 3Health News:Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find 2Health News:Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find 3Health News:Report on patients' access to cancer drugs 'uses flawed methods to reached flawed conclusions' 2Health News:Report on patients' access to cancer drugs 'uses flawed methods to reached flawed conclusions' 3Health News:Report on patients' access to cancer drugs 'uses flawed methods to reached flawed conclusions' 4Health News:Melanoma drug revs immune cells but cancer cells ignore it 2Health News:Scientists ID Likely Culprit in 'Popcorn Lung' 2Health News:Lack of sleep among new school-goers leads to behavioral, cognitive problems 2Health News:Lack of sleep among new school-goers leads to behavioral, cognitive problems 3
(Date:3/27/2015)... , March 27, 2015  The quality function ... description: ensure products meet quality standards at every stage ... escalating regulations, quality leaders also have the challenge of ... Those who don,t effectively balance these priorities ... well as marketplace failure and regulatory scrutiny. ...
(Date:3/27/2015)... 27, 2015 /PRNewswire/ - Medicure Inc. (the "Company") (TSXV:MPH, ... approved the grant of an aggregate of 236,070 options ... consultants of the Company pursuant to the Company,s Stock ... expire on the tenth anniversary of the date of ... anniversary of the date of grant and 50,000 are ...
(Date:3/27/2015)... March 27, 2015 Biopharmaceutical Industry Leads ... industry comes out on top as the country,s manufacturing ... new report  from ndp│analytics. According to the  analysis , ... investment over the last decade, accounting for 27 percent ... A Short Video on Medicare Part D ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2Week in Review: The Latest from PhRMA 2
... 2011 Signal Genetics, the parent company of Myeloma ... predictive genetic testing company focused on oncology, announced today ... Signal Genetics, new gene expression profile test for Multiple ... Myeloma Prognostic Risk Signature™ (MyPRS) ...
... NEW YORK, May 26, 2011 Lpath, Inc. (OTCBB: ... on RetailInvestorConferences.com on June 2, 2011 at 1:00 PM ... will discuss the company,s progress, including status updates on ... ocular drug candidate, iSONEP™, is being investigated in human ...
Cached Medicine Technology:Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test 2Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test 3Lpath CEO, Scott Pancoast, to Present Live Online at RetailInvestorConferences.com on June 2 at 1 PM EDT 2Lpath CEO, Scott Pancoast, to Present Live Online at RetailInvestorConferences.com on June 2 at 1 PM EDT 3
"Ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Complies with international standards of electrophysiology....
... The SL 130 Slit Lamp is an all-in-one ... optimally structured design also allows the SL 130 ... been achieved by the possibility of operating the ... the left or right hand. The instrument configuration ...
The SL 115 Classic Slit Lamp offers you high optical performance and convenient operation. It is not only the ideal instrument for all routine examinations and contact lens fitting, but is also excel...
... The UNFOLDER Silver-T is a refinement of ... to use. Offering proven ease of implantation, The ... lens 2-1/2 times faster than The UNFOLDER Silver ... a single twist, yet The UNFOLDER Silver-T provides ...
Medicine Products: